- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00915161
Sustained Effects of Thoracocentesis in Mechanically Ventilated Patients
Sustained Effects of Thoracocentesis in Mechanically Ventilated Patients: an Observational Single Centre Cohort Study
Collections of fluid around the lung (pleural effusions) are common in patients on mechanical ventilation. Long stays on mechanical ventilation can lead to serious complications such as pneumonia and are associated with significant morbidity and mortality. The drainage of pleural effusions may lead to improvements in oxygenation making it easier to discontinue mechanical ventilation.
The purpose of this study was to examine the effects of thoracocentesis (pleural fluid drainage) on blood oxygenation over a 48 hour period to see whether the effects are sustained and therefore helpful in this discontinuation.
Study Overview
Status
Conditions
Detailed Description
This will be a collection of data in patients in whom it has been decided by the attending clinician that pleural drainage would be beneficial. Ultrasound will be used to confirm the presence of pleural effusion and to estimate the size of the pleural effusions and to confirm the position of the pleural drain. Data will be collected before drainage, 30 minutes after drainage and then at 4,8,12 and 24 hours after the insertion of the drain (please see also attached summary of investigations). Measurements will include arterial blood gas analysis drawn from an indwelling arterial catheter, blood pressure, pulse, respiratory rate, mixed, expired CO2 and ventilator settings. The measurements will stop either at the end of the 48 hour period or when the team caring for the patient chose to remove the drain (whichever is the first).
All measurements including the arterial blood gas analysis form part of the standard care of an ICU patient. The arterial blood gas measurements are withdrawn from an indwelling arterial catheter which is routinely in place on all ICU patients. Only the use of thoracic ultrasound by a trained ultrasonographer both before and after the procedure will be additional to the standard care of the patient. The use of Chest X-rays is at the discretion of the treating clinician and does not form part of the study protocol. Standard biochemical, microbiological and cytological tests will be performed on the pleural fluid and blood in keeping with the standard practice for pleural effusions.
The primary outcome measure is the effects of drainage on the P:F ratio. measures of dead space ventilation, A-a gradiants, ventilator settings and dynamic compliance will also be assessed
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Oxon
-
Oxford, Oxon, United Kingdom, OX39DU
- John Radcliffe Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients on mechanical ventilation with evidence of pleural effusions on plain CXR confirmed to be large on bedside ultrasound in whom the attending clinician felt drainage would be beneficial
Exclusion Criteria:
- Coagulopathy
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The ratio of Partial pressure of oxygen to inspired concentration of oxygen (P:F ratio)
Time Frame: pre-procedure, 30 minutes, 4,8,24 and 48 hours post procedure
|
pre-procedure, 30 minutes, 4,8,24 and 48 hours post procedure
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Effects on A-a gradients, dead space ventilation, ventilator settings and dynamic compliance
Time Frame: pre-procedure, 30minutes, 4,8,24 and 48 hours post procedure
|
pre-procedure, 30minutes, 4,8,24 and 48 hours post procedure
|
Collaborators and Investigators
Investigators
- Principal Investigator: andrew p walden, PhD, Oxford University Hospitals NHS Trust
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MREC-07/H0505/197
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pleural Effusion
-
Naestved HospitalTerminatedMalignant Pleural Effusion | Exudative Pleural EffusionDenmark
-
Oregon Health and Science UniversityThe Gerber FoundationCompletedChylous Pleural Effusion Following Cardiothoracic SurgeryUnited States
-
Sheng HuWuhan Binhui Biotechnology Co., Ltd.RecruitingMalignant Pleural Effusion | Malignant Peritoneal EffusionChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPleural NeoplasmUnited States
-
Clover Biopharmaceuticals AUS Pty LtdCompletedMalignant Pleural EffusionsAustralia
-
JemincareZhejiang Hangyu Pharmaceutical Co., LtdRecruitingMalignant Pleural EffusionChina
-
National University of Ireland, Galway, IrelandRecruitingMalignant Pleural EffusionIreland
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Not yet recruiting
-
Washington University School of MedicineMerit Medical Systems, Inc.CompletedMalignant Pleural EffusionUnited States
-
Duke UniversityTerminated